AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosisShuraila F. Zerp, Marcel Verheij|Radiation Oncology|2009Cited by 58
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancerShuraila F. Zerp, Marcel Verheij|Radiation Oncology|2015Cited by 49
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model systemShuraila F. Zerp, Marcel Verheij|Clinical and Translational Radiation Oncology|2020Cited by 9